Overview
Availability
- Professor Scott Bell is:
- Available for supervision
Fields of research
Works
Search Professor Scott Bell’s works on UQ eSpace
2003
Journal Article
The genomovar distribution of Burkholderia cepacia complex isolates collected from Australian cystic fibrosis units
Kidd, T. J., Bell, S. C. and Coulter, C. (2003). The genomovar distribution of Burkholderia cepacia complex isolates collected from Australian cystic fibrosis units. Journal of Cystic Fibrosis, 2 (1 Suppl), S33-S33.
2003
Conference Publication
Vitamin A is associated with the inflammatory marker CRP in cystic fibrosis
Greer, R., Buntain, H. M., Wainwright, C. E., Batch, J. A., Francis, P. W. and Bell, S. C. (2003). Vitamin A is associated with the inflammatory marker CRP in cystic fibrosis. 26th Congress of the European Cystic Fibrosis Society, Belfast, Ireland, 5 Jun, 2003. Amsterdam: Elsevier BV. doi: 10.1016/j.jcf.2004.06.005
2003
Conference Publication
Presence of epidemic Pseudomonas aeruginosa shared between paediatric and adult cystic fibrosis
O'Carroll, M. R., Bell, S. C., Coulter, C., Wainwright, C. E., Nissen, M., Sloots, T. and Syrmis, M. (2003). Presence of epidemic Pseudomonas aeruginosa shared between paediatric and adult cystic fibrosis. TSANZ 2003 Annual Scientific Meeting, Adelaide, Australia, 4-9 April, 2003. Carlton South, Australia: doi: 10.1111/j.1440-1843.2003.supp_1.x
2003
Conference Publication
Gender differences in CF phenotype associated with low bone mineral density
Greer, R., Bell, S. C., O'Rourke, P., Buntain, H., Batch, J. and Francis, P. (2003). Gender differences in CF phenotype associated with low bone mineral density. 26th European CF Conference, Belfast, Ireland, June 5–7 2003. The Netherlands: Elsevier. doi: 10.1016/S1569-1993(03)00027-4
2002
Journal Article
Novel application of biological glue in the management of a complicated pneumothorax in cystic fibrosis
Garske, Luke A., Tam, Robert K.W., Windsor, Morgan F. and Bell, Scott C. (2002). Novel application of biological glue in the management of a complicated pneumothorax in cystic fibrosis. Pediatric Pulmonology, 34 (2), 138-140. doi: 10.1002/ppul.10112
2002
Journal Article
Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial
Wolter, J., Seeney, S., Bell, S., Bowler, S., Masel, P. and McCormack, J. (2002). Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. Thorax, 57 (3), 212-216. doi: 10.1136/thorax.57.3.212
2002
Journal Article
Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: A randomised trial
Wolter, J., Seeney, S., Bell, S., Bowler, S., Masel, P. and McCormack, J. (2002). Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: A randomised trial. Thorax, 57 (3), 212-216. doi: 10.1136/thorax.57.3.212
2002
Journal Article
Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosis
Garske, L. A. and Bell, S. C. (2002). Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosis. Chest, 121 (4), 1363-1364. doi: 10.1378/chest.121.4.1363
2002
Conference Publication
Rifampicin and fusidic acid reduces the frequency of MRSA isolation and need for intravenous antibiotics in adult patients with cystic fibrosis and chronic MRSA infection
Garske, L., Bunting, J., Franks, C., Masel, P. and Bell, S. (2002). Rifampicin and fusidic acid reduces the frequency of MRSA isolation and need for intravenous antibiotics in adult patients with cystic fibrosis and chronic MRSA infection. TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia.
2002
Conference Publication
Long-term treatment with azithromycin results in reduced ex-vivo inflammatory cytokine production in adults with cystic fibrosis
Bell, S. C., Seeney, S., Walmsley, K., Wolter, J. M., Bowler, S. D. and McCormack, J. G. (2002). Long-term treatment with azithromycin results in reduced ex-vivo inflammatory cytokine production in adults with cystic fibrosis. 16th Annual North American Cystic Fibrosis Conference, Louisiana, USA, 3-6 October, 2002. New York: Wiley-Liss. doi: 10.1002/ppul.70010
2002
Conference Publication
A study of the use of complementary and alternative medicines (CAM) in adults with cystic fibrosis (CF)
Phillips, J., Bajramovic, J. and Bell, S. (2002). A study of the use of complementary and alternative medicines (CAM) in adults with cystic fibrosis (CF). TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia.
2002
Conference Publication
Antibiotic desensitisation in adults with cystic fibrosis
Burrows, J., Toon, M. and Bell, S. C. (2002). Antibiotic desensitisation in adults with cystic fibrosis. SHPA State Conference 2002 - Reducing risk: the cornerstone of hospital pharmacy, Brisbane, 1-3 Nov. 2002. Brisbane: SHPA Qld.
2002
Conference Publication
Long-term treatment with azithromycin results in reduced in vitro inflammatory cytokine production in adults with cystic fibrosis
Bowler, S. D., Seeney, S., Walmsley, K., Wolter, J.M., Bell, S. C. and McCormack, J. G. (2002). Long-term treatment with azithromycin results in reduced in vitro inflammatory cytokine production in adults with cystic fibrosis. TSANZ Annual Scientific Meeting, Cairns, Queensland, 22-27 March, 2002. Carlton: Blackwell Asia. doi: 10.1111/j.1440-1843.2004.supp_1.x
2002
Conference Publication
Portrait of the cystic fibrosis (CF) patient in Australia and New Zealand (NZ) in 1999
Cooper, P., McKay, K., Bobosevich, Z. and Bell, S. (2002). Portrait of the cystic fibrosis (CF) patient in Australia and New Zealand (NZ) in 1999. TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia.
2002
Journal Article
Optimising nutrition in cystic fibrosis
Bell, S. C. and Shepherd, R. W. (2002). Optimising nutrition in cystic fibrosis. Journal of Cystic Fibrosis, 1 (2), 47-50. doi: 10.1016/S1569-1993(02)00031-0
2002
Conference Publication
Cost of providing nutritional support for adult patients with cystif fibrosis (CF)
McMillan, J., Matson, A., Matson, K. and Bell, S. (2002). Cost of providing nutritional support for adult patients with cystif fibrosis (CF). TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia.
2002
Journal Article
Prevalence of complementary and alternative medicine use by adults with cystic fibrosis
Burrows, J. A., Bajramovic, J. and Bell, S. C. (2002). Prevalence of complementary and alternative medicine use by adults with cystic fibrosis. Journal of Pharmacy Practice and Research, 32 (4), 320-323. doi: 10.1002/jppr2002324320
2002
Conference Publication
Prevalence of cystic fibrosis-related diabetes (CFRD), in an Australian adult cystic fibrosis (CF) unit
Matson, A. G., Walker, F., Matson, K. M. and Bell, S. (2002). Prevalence of cystic fibrosis-related diabetes (CFRD), in an Australian adult cystic fibrosis (CF) unit. 16th Annual North American Cystic Fibrosis Conference, Louisiana, 3-6 Oct, 2002. New York: Wiley-Liss.
2002
Conference Publication
Calcium homeostasis in patients with cystic fibrosis
Greer, R., Buntain, H., Wainwright, C., Wong, J., Lewindon, P., Potter, J., Francis, P., O'Rourke, P., Munns, C., Batch, J. and Bell, S. (2002). Calcium homeostasis in patients with cystic fibrosis. TSANZ Annual Scientific Meeting, Cairns, QLD, Australia, 22-27 March 2002. Carlton, VIC, Australia: Blackwell Asia. doi: 10.1111/j.1440-1843.2004.supp_2.x
2002
Conference Publication
Burkholderia cepacia (b.cepacia) complex: identification of genomovars in patients with cystic fibrosis (CF)
Kidd, T., Coulter, C. and Bell, S. (2002). Burkholderia cepacia (b.cepacia) complex: identification of genomovars in patients with cystic fibrosis (CF). TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia.
Funding
Current funding
Supervision
Availability
- Professor Scott Bell is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Risk and mitigation of cough aerosols for people with cystic fibrosis.
Principal Advisor
Other advisors: Professor Rachel Thomson
-
Doctor Philosophy
The Pharmacokinetics & Pharmacodynamics of Antimycobacterial Drugs in People with Cystic Fibrosis and Drug-Resistant Tuberculosis Infection
Associate Advisor
Other advisors: Professor Rachel Thomson, Professor Jason Roberts
Completed supervision
-
2019
Doctor Philosophy
Impact of built environment, personal protective devices and ventilation on the dispersion of respiratory pathogens
Principal Advisor
-
2019
Master Philosophy
Infectious airborne transport in individuals with cystic fibrosis and mitigation strategies to reduce aerosol dispersal
Principal Advisor
-
2018
Doctor Philosophy
Diversity of environmental and clinical Pseudomonas aeruginosa isolates
Principal Advisor
Other advisors: Associate Professor David Whiley
-
2016
Doctor Philosophy
Heterogeneity within Pseudomonas aeruginosa shared strains in cystic fibrosis: the development and spread of antimicrobial resistance
Principal Advisor
Other advisors: Associate Professor David Whiley
-
2012
Doctor Philosophy
Diagnosis, epidemiology and population structure of Pseudomonas aeruginosa in cystic fibrosis.
Principal Advisor
-
2022
Doctor Philosophy
The effectiveness of ultraviolet C light at inactivating airborne Pseudomonas aeruginosa and Mycobacterium abscessus
Associate Advisor
-
2022
Doctor Philosophy
Deep Sequencing of Microbial Communities in Cystic Fibrosis Airways
Associate Advisor
Other advisors: Professor Ian Henderson
Media
Enquiries
For media enquiries about Professor Scott Bell's areas of expertise, story ideas and help finding experts, contact our Media team: